Advanced search
Publication Cover
Leukemia & Lymphoma Volume 61, 2020 - Issue 4
Submit an article Journal homepage
295
Views
9
CrossRef citations to date
0
Altmetric
Original Articles

Time from first symptom onset to the final diagnosis of multiple myeloma (MM) – possible risks and future solutions: retrospective and prospective ‘Deutsche Studiengruppe MM’ (DSMM) and ‘European Myeloma Network’ (EMN) analysis*

Giulia GrazianiDepartment of Medicine, Hematology and Oncology, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany; View further author information
,
Georg W. HergetDepartment of Orthopedics and Trauma Surgery, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany; ;Comprehensive Cancer Center Freiburg (CCCF), Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany; View further author information
,
Gabriele IhorstClinical Trials Unit, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany; View further author information
,
Mara ZeissigMyeloma Research Laboratory, Adelaide Medical School, Faculty of Health and Medical Sciences, University of Adelaide, Adelaide, Australia; ;Precision Medicine Theme, South Australian Health and Medical Research Institute, Adelaide, Australia; View further author information
,
Aristeidis ChaidosCentre for Hematology, Imperial College London, London, UKView further author information
,
Holger W. AunerCentre for Hematology, Imperial College London, London, UKView further author information
,
Justus DuysterDepartment of Medicine, Hematology and Oncology, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany; ;Comprehensive Cancer Center Freiburg (CCCF), Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany; View further author information
,
Ralph WäschDepartment of Medicine, Hematology and Oncology, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany; ;Comprehensive Cancer Center Freiburg (CCCF), Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany; View further author information
&
Monika EngelhardtDepartment of Medicine, Hematology and Oncology, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany; ;Comprehensive Cancer Center Freiburg (CCCF), Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany; Correspondence[email protected]
View further author information
 show all
Pages 875-886 | Received 06 Sep 2019, Accepted 06 Nov 2019, Published online: 28 Nov 2019

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.